Approval · Notice of Compliance 10754 · 2009
NU-CEFPROZIL: Notice of Compliance 10754
Issued November 5, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10754
- Date
- November 5, 2009
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antibiotic
- Canadian reference product
- CEFZIL (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-CEFPROZIL | 02336340 | Cancelled (Unreturned Annual) |
| NU-CEFPROZIL | 02336359 | Cancelled (Unreturned Annual) |